Neuraxis (NRXS) Liabilities and Shareholders Equity (2022 - 2025)

Neuraxis has reported Liabilities and Shareholders Equity for 4 years, with the latest figure at $6.4 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity rose 34.61% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $19.3 million (up 66.62% YoY) and the FY2025 annual result came in at $6.4 million, up 34.61% from the prior year.
• Liabilities and Shareholders Equity rose to $6.4 million in Q4 2025 per NRXS's latest filing, from $5.8 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $7.1 million in Q2 2025 and troughed at $509498.0 in Q4 2023.
• A 4-year average of $3.0 million and a median of $2.1 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity sank 65.59% in 2023, then soared 833.78% in 2024.
• Over 4 years, Liabilities and Shareholders Equity stood at $1.5 million in 2022, then tumbled by 65.59% to $509498.0 in 2023, then jumped by 833.78% to $4.8 million in 2024, then soared by 34.61% to $6.4 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $6.4 million, $5.8 million, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.